Related Experiment Videos
Is dopamine-agonist induced yawning behavior a D3 mediated event?
1Department of Pharmacology, James H. Quillen College of Medicine, East Tennessee State University, Johnson City 37614.
Life Sciences
|January 1, 1991
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Pharmacological models of ADHD.
Journal of neural transmission (Vienna, Austria : 1996)·2007
Effect of ketanserin and amphetamine on nigrostriatal neurotransmission and reactive oxygen species in Parkinsonian rats. In vivo microdialysis study.
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2007
Proposed animal model of severe Parkinson's disease: neonatal 6-hydroxydopamine lesion of dopaminergic innervation of striatum.
Journal of neural transmission. Supplementum·2006
Review of apoptosis vs. necrosis of substantia nigra pars compacta in Parkinson's disease.
Neurotoxicity research·2006
Neuroprotective and neurorestorative strategies for neuronal injury.
Neurotoxicity research·2006
Reliable Apparent Permeability Prediction Through Benchmarking, Stability, Uncertainty Quantification, and Explainable Machine Learning.
CPT: pharmacometrics & systems pharmacology·2026
Is drug development in India is responsive to disease burden: A descriptive study.
Perspectives in clinical research·2026
Exploring New Treatment Strategies for Endometriosis-Narrative Review.
International journal of molecular sciences·2026